Robert Bourge is a Cardiology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 314 publications with 24,846 citations (h-index 70); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2000 6th Ave S
Birmingham, AL 352332110
Telephone
205-801-8000Registry record last updated 29 Jun 2023.
Clinical trials
- Implantable System for Remodulin Post-Approval Study
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
- Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
Sponsor: University of Alabama at Birmingham
- Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20231 payment
- AI Therapeutics, Inc.Program year20221 payment
- Abbott LaboratoriesProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1997–2000 per NIH RePORTER. The latest:
- TRIAL OF BG9719/FUROSEMIDE IN CHF &RENAL INSUFFICIENCY
University of Alabama at Birmingham
FY2000M01RR000032 - MULTIPLE DOSE ORAL RS25560197 SUSPENSION IN CONGESTIVE HEART FAILURE
University of Alabama at Birmingham
FY1999M01RR000032 - MULTIPLE DOSE ORAL RS25560197 SUSPENSION IN CONGESTIVE HEART FAILURE
University of Alabama at Birmingham
FY1998M01RR000032
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction
Journal of the American College of Cardiology
2017 - Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor
Circulation Heart Failure
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”